Table II.

Clinical characteristics of participants without and with metabolic syndrome.

	Participants without MetS	Participants with MetS	p
Glucose, mmol/L*	5.20 (4.90–5.80)	5.90 (5.40–6.47)	<0.001
HbA1c, %**	4.94 (4.80–5.08)	5.40 (5.29–5.55)	<0.001
TC, mmol/ L	5.52±1.14	5.74±1.33	0.345
HDL-c, mmol/L	1.59±0.42	1.34±0.36	<0.001
LDL-c, mmol/L**	3.18 (2.95–3.43)	3.39 (3.07–3.74)	0.303
TG, mmol/L**	1.29 (1.13–1.46)	1.91 (1.73–2.10)	<0.001
hsCRP, mg/L*	1.24 (0.97–1.58)	2.19 (1.77–2.72)	0.001
Bilirubin, mmol/L**	7.46 (6.62–8.41)	7.16 (6.31–8.14)	0.644
Uric acid, μmol/L	264.07±74.77	316.94±68.34	<0.001
Creatinine, μmol/L**	69.31 (65.57–73.27)	73.27 (69.10–77.70)	0.171
eGFR-MDRD, mL/min/1.73 m2	88.22±20.90	82.69±18.44	0.148
AST, U/L*	19 (17–22)	21 (18–26)	0.044
ALT, U/L*	18 (14–23)	25 (19–35)	<0.001
GGT, U/L*	13 (12–18)	19 (14–30)	0.001
XOD, U/L	325.34±61.79	351.60±72.77	0.044
XO, U/L*	127.40 (110.25–142.10)	144.55 (122.50–175.15)	0.012
XDH, U/L	194.48±80.05	199.94±83.10	0.728
MDA, μmol/L	49.74±7.28	54.15±8.25	0.004
AOPP, T/L	67.81 (58.23–118.17)	74.70 (68.17–130.53)	0.010
CAT, U/L	75.06±45.19	66.92±43.54	0.342
NOx, μmol/L	37.69 (32.47–54.69)	40.02 (33.36–49.69)	0.913

Data are presented as arithmetic mean ± SD and compared by Student t-test.

* Skewed distributed data are presented as median (interquartile range) and compared by Mann-Whitney test.

** Log-normal distributed data are presented as geometric mean (95% CI) compared by Student t-test. HbA1c-Glycated hemoglobin; TC-Total cholesterol; HDL-c-High density lipoprotein cholesterol; LDL-c-Low density lipoprotein cholesterol; TG-Triglycerides; hsCRP-High-sensitivity C-reactive protein; eGFRMDRD-Estimated glomerular filtration rate; AST-Aspartate aminotransferase; ALT-Alanine aminotransferase; GGT-Gamma-glutamyl transferase; XOD-Xanthine oxidoreductase; XO-Xanthine oxidase; XDH-Xanthine dehydrogenase; MDA- Malondialdehyde; AOPP-Advanced oxidation protein products; CAT-Catalase; NOx-Nitric oxide products